Arabic Arabic English English French French German German

Efficacy of berberine in treatment of rheumatoid arthritis.


Pharmacol Res. 2021 May 11:105667. Epub 2021 May 11. PMID: 33989762

Abstract Title: 

Efficacy of Berberine in Treatment of Rheumatoid Arthritis: from Multiple Targets to Therapeutic Potential.


Rheumatoid arthritis is a systemic autoimmune disorder involved in persistent synovial inflammation. Berberine is a nature-derived alkaloid compound with multiple pharmacological activities in different pathologies, including RA. Recent experimental studies have clarified several determinant cellular and molecular targets of BBR in RA, and provided novel evidence supporting the promising therapeutic potential of BBR to combat RA. In this review, we recapitulate the therapeutic potential of BBR and its mechanism of action in ameliorating RA, and discuss the modulation of gut microbiota by BBR during RA. Collectively, BBR might be a promising lead drug with multi-functional activities for the therapeutic strategy of RA.

read more

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Benzyl and phenethyl isothiocyanates as promising epigenetic drug compounds by modulating histone acetylation and methylation marks in malignant melanoma.

Next Post

Berberine attenuates the inflammatory response by activating the Keap1/Nrf2 signaling pathway in bovine endometrial epithelial cells.

Related Posts